TIDMHIK

RNS Number : 8100Q

Hikma Pharmaceuticals Plc

23 June 2020

TR-1: S tandard form for notification of major holdings

LONDON, 23 June 2020 - Hikma Pharmaceuticals PLC (LEI: 549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) announces as follows:

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible) (i) 
 
 1a. Identity of the issuer or the                                  Hikma Pharmaceuticals PLC 
  underlying issuer of existing shares 
  to which voting rights are attached 
  (ii) : 
                                                          --------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                   ---- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights 
                                                                                                   ---- 
 An acquisition or disposal of financial instruments 
                                                                                                   ---- 
 An event changing the breakdown of voting rights                                                    X 
                                                                                                   ---- 
 Other (please specify)(iii) : 
                                                                                                   ---- 
 3. Details of person subject to the notification obligation (iv) 
 Name                                                      Darhold Limited 
 City and country of registered office                     St Helier, Jersey 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.) (v) 
 Name 
                                                          --------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                          --------------------------------------------- 
 5. Date on which the threshold was                        23/06/2020 
  crossed or reached (vi) : 
                                                          --------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):            23/06/2020 
                                                          --------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                            % of voting       % of voting rights    Total of both   Total number 
                           rights attached     through financial     in % (8.A +     of voting rights 
                              to shares           instruments            8.B)        of issuer (vii) 
                              (total of          (total of 8.B 
                                8. A)             1 + 8.B 2) 
                         -----------------  ---------------------  --------------  -------------------- 
 Resulting situation 
  on the date on 
  which threshold 
  was crossed or 
  reached                 26.04%             0.00%                  26.04%          230,449,839 
                         -----------------  ---------------------  --------------  -------------------- 
 Position of previous 
  notification (if 
  applicable)             24.66%             0.00%                  24.66% 
                         -----------------  ---------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which 
  the threshold was crossed or reached (viii) 
 A: Voting rights attached to shares 
 Class/type of        Number of voting rights                                        % of voting rights 
  shares               (ix) 
  ISIN code (if 
  possible) 
                               Direct                         Indirect                       Direct                   Indirect 
                         (Art 9 of Directive            (Art 10 of Directive           (Art 9 of Directive      (Art 10 of Directive 
                             2004/109/EC)                   2004/109/EC)              2004/109/EC) (DTR5.1)         2004/109/EC) 
                               (DTR5.1)                      (DTR5.2.1)                                              (DTR5.2.1) 
                                                 --------------------------------- 
 GB00B0LCW083          60,000,000                 0                                  26.04%                    0.00% 
                     --------------------------  ---------------------------------  ------------------------  ----------------------- 
 
 
 SUBTOTAL 8. A                                 60,000,000                                                 26.04% 
                     -------------------------------------------------------------  ------------------------------------------------- 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of financial    Expiration       Exercise/                            Number of voting                   % of voting 
  instrument           date             Conversion Period                    rights that may                    rights 
                       (x)              (xi)                                 be acquired if 
                                                                             the instrument 
                                                                             is 
                                                                             exercised/converted. 
                     ---------------  -----------------------------------  ---------------------------------  ----------------------- 
 N/A 
                     ---------------  -----------------------------------  ---------------------------------  ----------------------- 
 
 
                                       SUBTOTAL 8. B 1 
                                      -----------------------------------  ---------------------------------  ----------------------- 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of       Expiration              Exercise/               Physical or                 Number of           % of voting 
  financial     date (x)                Conversion              cash                        voting rights       rights 
  instrument                            Period (xi)             settlement 
                                                                (xii) 
              ----------------------  ----------------------  --------------------------  ------------------ 
 N/A 
                     ---------------  ----------------------  --------------------------  ------------------ 
 
 
                                                               SUBTOTAL 8.B.2 
                                                              --------------------------  ------------------ 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled                                                                  X 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer (xiii) 
 Full chain of controlled undertakings through which the voting rights 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity (xiv) (please add additional 
  rows as necessary) 
         Name (xv)                     % of voting rights                    % of voting rights                Total of both if 
                                         if it equals or                      through financial                 it equals or is 
                                        is higher than the                    instruments if it                 higher than the 
                                       notifiable threshold                  equals or is higher             notifiable threshold 
                                                                             than the notifiable 
                                                                                  threshold 
                            ----------------------------------------  --------------------------------  ----------------------------- 
 N/A 
                            ----------------------------------------  --------------------------------  ----------------------------- 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder                                              N/A 
                                                                      --------------------------------------------------------------- 
 The number and % of voting rights 
  held 
                                                                      --------------------------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                                                      --------------------------------------------------------------- 
 
 11. Additional information (xvi) 
 
 
 
 
 Place of completion   London 
 Date of completion    23/06/2020 
                      ----------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLUOORRRSUNUAR

(END) Dow Jones Newswires

June 23, 2020 06:39 ET (10:39 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Lug 2020 a Ago 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Ago 2019 a Ago 2020 Clicca qui per i Grafici di Hikma Pharmaceuticals